Type 2 inflammation reduces SARS-CoV-2 replication in the airway epithelium in allergic asthma through functional alteration of ciliated epithelial cells

Despite well-known susceptibilities to other respiratory viral infections, individuals with allergic asthma have shown reduced susceptibility to severe coronavirus disease 2019 (COVID-19).

Source: Journal of Allergy and Clinical Immunology - March 29, 2023 Category: Allergy & Immunology Authors: Naresh Doni Jayavelu, Matthew C. Altman, Basilin Benson, Matthew J. Dufort, Elizabeth R. Vanderwall, Lucille M. Rich, Maria P. White, Patrice M. Becker, Alkis Togias, Daniel J. Jackson, Jason S. Debley Source Type: research